Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

BASF's new ET antagonists described in patent literature

Sep. 16, 1999

Cypros receives additional notice of allowance concerning U.S. patent on Cordox

Sep. 16, 1999

Modulators of cGMP production in development at HMR

Sep. 15, 1999

BiDil combination therapy offers benefits for black CHF patients

Sep. 15, 1999

Promising data on Resten-NG presented at international cardiology conference

Sep. 15, 1999

Endothelin antagonists described by BMS for hypertension, etc.

Sep. 14, 1999

Nonimmunosuppressive cytokine synthesis inhibitor effective in murine model of septic shock

Sep. 14, 1999

Medinox's NOX-100 demonstrates potential as treatment of hemorrhagic shock

Sep. 13, 1999

Potent and selective, optically active alpha1-adrenoceptor ligands developed in Taiwan

Sep. 10, 1999

Allosteric adenosine receptor modulators described by Medco

Sep. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...